Based on Your Reading:
Get a Mesothelioma Treatment Guide

Find a Top Mesothelioma Doctor

Access Help Paying for Treatment

Vinorelbine, also known by the brand name Navelbine, is a chemotherapy drug that has been tested as a second-line treatment for mesothelioma, both as a single agent and in combination with other drugs such as cisplatin or gemcitabine.
Written by Karen Selby, RN • Edited By Walter Pacheco • Medically Reviewed By Dr. Jeffrey Velotta
The Mesothelioma Center at Asbestos.com has provided patients and their loved ones the most updated and reliable information on mesothelioma and asbestos exposure since 2006.
Our team of Patient Advocates includes a medical doctor, a registered nurse, health services administrators, veterans, VA-accredited Claims Agents, an oncology patient navigator and hospice care expert. Their combined expertise means we help any mesothelioma patient or loved one through every step of their cancer journey.
More than 30 contributors, including mesothelioma doctors, survivors, health care professionals and other experts, have peer-reviewed our website and written unique research-driven articles to ensure you get the highest-quality medical and health information.
My family has only the highest compliment for the assistance and support that we received from The Mesothelioma Center. This is a staff of compassionate and knowledgeable individuals who respect what your family is experiencing and who go the extra mile to make an unfortunate diagnosis less stressful. Information and assistance were provided by The Mesothelioma Center at no cost to our family.LashawnMesothelioma patient’s daughter
Selby, K. (2023, June 21). Vinorelbine. Asbestos.com. Retrieved December 5, 2023, from https://www.asbestos.com/treatment/chemotherapy/vinorelbine/
Selby, Karen. "Vinorelbine." Asbestos.com, 21 Jun 2023, https://www.asbestos.com/treatment/chemotherapy/vinorelbine/.
Selby, Karen. "Vinorelbine." Asbestos.com. Last modified June 21, 2023. https://www.asbestos.com/treatment/chemotherapy/vinorelbine/.
Vinorelbine belongs to a family of chemotherapy drugs known as vinca alkaloids. They were first created from extracts of the periwinkle plant. Researchers discovered the antitumor effects of this drug in 1959.
Vinorelbine is classified as an antineoplastic agent. It binds to microtubular proteins in cells. Microtubules aid cell reproduction. Vinorelbine prevents cancer cells from reproducing and leads to their self-destruction.
Doctors administer vinorelbine in cycles of six weekly intravenous (IV) injections. This varies based on the patient’s health factors and whether vinorelbine is combined with another chemotherapy drug.
Get a Mesothelioma Treatment Guide
Find a Top Mesothelioma Doctor
Access Help Paying for Treatment
Vinorelbine regimens are not as effective as pemetrexed and cisplatin treatment for mesothelioma. Vinorelbine has shown some effectiveness and has relatively low toxicity. Doctors have continued to explore its value as a palliative or second-line therapy.
A 2017 study reviewed second-line chemotherapy treatment for mesothelioma. International guidelines include vinorelbine as a suggested drug. Yet the research evidence supporting its use is inconclusive.
The Wales Cancer Trials Unit is studying the effectiveness of vinorelbine as a second-line treatment. The researchers also aim to determine whether the BRCA1 gene is required for vinorelbine to cause cancer-cell death.
A 2021 study discovered that vinorelbine is less effective in people with a BRCA1/MAD2L1 genetic deficiency.
Our free mesothelioma guide contains information on symptoms, top doctors, support resources and more. Get information tailored to your unique diagnosis, and learn about our free services.
Your web browser is no longer supported by Microsoft. Update your browser for more security, speed and compatibility.
If you are looking for mesothelioma support, please contact our Patient Advocates at (855) 404-4592